Tilray Brands, Inc. (TLRY.TO)
CAD 0.63
(-4.55%)
CAD 0.63
(-4.55%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -244.98 Million USD | 83.02% |
| 2022 | -1.44 Billion USD | -232.39% |
| 2021 | -434.13 Million USD | -29.2% |
| 2020 | -336.01 Million USD | -450.69% |
| 2019 | -61.01 Million USD | -400.36% |
| 2018 | -12.19 Million USD | -153.4% |
| 2017 | 22.83 Million USD | 632.79% |
| 2016 | 3.11 Million USD | 921.38% |
| 2015 | 305.12 Thousand USD | 105.8% |
| 2014 | -5.26 Million USD | -295.35% |
| 2013 | -1.33 Million USD | -3071.66% |
| 2012 | -41.98 Thousand USD | 56.46% |
| 2011 | -96.42 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -39.16 Million USD | 53.38% |
| 2023 FY | -244.98 Million USD | 83.02% |
| 2023 Q4 | -31.74 Million USD | 65.75% |
| 2023 Q3 | -92.7 Million USD | -89.15% |
| 2023 Q2 | -49 Million USD | 12.27% |
| 2023 Q1 | -55.86 Million USD | 53.38% |
| 2022 Q4 | -119.81 Million USD | 89.98% |
| 2022 Q2 | -61.63 Million USD | 6.32% |
| 2022 Q3 | -1.19 Billion USD | -1840.05% |
| 2022 Q1 | -65.79 Million USD | 85.63% |
| 2022 FY | -1.44 Billion USD | -232.39% |
| 2021 Q2 | 5.79 Million USD | 113.92% |
| 2021 Q1 | -41.64 Million USD | -223.94% |
| 2021 Q3 | 43.19 Million USD | 645.04% |
| 2021 FY | -434.13 Million USD | -29.2% |
| 2021 Q4 | -457.8 Million USD | -1159.97% |
| 2020 Q2 | -92.87 Million USD | -2284.85% |
| 2020 Q3 | -283.3 Million USD | -205.02% |
| 2020 FY | -336.01 Million USD | -450.69% |
| 2020 Q4 | 33.6 Million USD | 111.86% |
| 2020 Q1 | -3.89 Million USD | 94.53% |
| 2019 Q4 | -71.26 Million USD | -1775.75% |
| 2019 Q1 | 12.3 Million USD | -0.34% |
| 2019 Q2 | -5.96 Million USD | -148.5% |
| 2019 Q3 | 4.25 Million USD | 171.27% |
| 2019 FY | -61.01 Million USD | -400.36% |
| 2018 Q1 | 16.3 Million USD | 495.53% |
| 2018 Q4 | 12.34 Million USD | 115.0% |
| 2018 FY | -12.19 Million USD | -153.4% |
| 2018 Q3 | -82.3 Million USD | -299.52% |
| 2018 Q2 | 41.25 Million USD | 153.01% |
| 2017 Q2 | 5.01 Million USD | -57.9% |
| 2017 FY | 22.83 Million USD | 632.79% |
| 2017 Q4 | -4.12 Million USD | -140.68% |
| 2017 Q3 | 10.13 Million USD | 102.01% |
| 2017 Q1 | 11.91 Million USD | 686.38% |
| 2016 Q1 | 683.89 Thousand USD | -29.67% |
| 2016 FY | 3.11 Million USD | 921.38% |
| 2016 Q3 | 3.75 Million USD | 433.16% |
| 2016 Q4 | -2.03 Million USD | -154.14% |
| 2016 Q2 | 703.87 Thousand USD | 2.92% |
| 2015 Q4 | 972.37 Thousand USD | 35321.48% |
| 2015 Q3 | 2745.16 USD | 100.85% |
| 2015 Q1 | -360.08 Thousand USD | 14.27% |
| 2015 FY | 305.12 Thousand USD | 105.8% |
| 2015 Q2 | -322.41 Thousand USD | 10.46% |
| 2014 Q1 | -7840.70 USD | 87.46% |
| 2014 Q4 | -420 Thousand USD | 83.07% |
| 2014 Q3 | -2.48 Million USD | -40472.45% |
| 2014 FY | -5.26 Million USD | -295.35% |
| 2014 Q2 | -6112.93 USD | 22.04% |
| 2013 Q1 | -6954.06 USD | -89.61% |
| 2013 Q4 | -62.52 Thousand USD | -34.35% |
| 2013 Q3 | -46.54 Thousand USD | -1137.19% |
| 2013 Q2 | -3761.96 USD | 45.9% |
| 2013 FY | -1.33 Million USD | -3071.66% |
| 2012 Q2 | -19.48 Thousand USD | -52.65% |
| 2012 Q3 | -12.67 Thousand USD | 34.95% |
| 2012 Q4 | -3667.48 USD | 71.07% |
| 2012 Q1 | -12.76 Thousand USD | 25.74% |
| 2012 FY | -41.98 Thousand USD | 56.46% |
| 2011 Q2 | -3424.37 USD | 0.0% |
| 2011 Q4 | -17.18 Thousand USD | 73.7% |
| 2011 FY | -96.42 Thousand USD | 0.0% |
| 2011 Q3 | -65.34 Thousand USD | -1808.27% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Aurora Cannabis Inc. | -69.32 Million CAD | -253.375% |
| Avicanna Inc. | -8.74 Million CAD | -2702.024% |
| Avant Brands Inc. | -5.07 Million CAD | -4731.972% |
| Cardiol Therapeutics Inc. | -28.12 Million CAD | -770.942% |
| Crescita Therapeutics Inc. | -1.98 Million CAD | -12235.398% |
| Knight Therapeutics Inc. | -16.83 Million CAD | -1355.189% |
| MediPharm Labs Corp. | -13.08 Million CAD | -1772.514% |
| OrganiGram Holdings Inc. | -229.47 Million CAD | -6.756% |
| Canopy Growth Corporation | -657.26 Million CAD | 62.727% |
| Willow Biosciences Inc. | -13.02 Million CAD | -1780.275% |
| Auxly Cannabis Group Inc. | -44.51 Million CAD | -450.383% |